Form 8-K - Current report:
SEC Accession No. 0000950170-25-105027
Filing Date
2025-08-07
Accepted
2025-08-07 16:10:58
Documents
12
Period of Report
2025-08-07
Items
Item 2.02: Results of Operations and Financial Condition

Document Format Files

Seq Description Document Type Size
1 8-K rxst-20250807.htm   iXBRL 8-K 47942
2 EX-99.1 rxst-ex99_1.htm EX-99.1 390469
3 GRAPHIC img261313502_0.jpg GRAPHIC 2587
  Complete submission text file 0000950170-25-105027.txt   562276

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT rxst-20250807.xsd EX-101.SCH 23863
14 EXTRACTED XBRL INSTANCE DOCUMENT rxst-20250807_htm.xml XML 4511
Mailing Address 100 COLUMBIA STREET SUITE 120 ALISO VIEJO CA 92656
Business Address 100 COLUMBIA STREET SUITE 120 ALISO VIEJO CA 92656 949-521-7822
RxSight, Inc. (Filer) CIK: 0001111485 (see all company filings)

EIN.: 943268801 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40690 | Film No.: 251194092
SIC: 3851 Ophthalmic Goods
(CF Office: 08 Industrial Applications and Services)